A critical review of the full economic evaluations of pharmacological treatments for colorectal cancer

Livio Garattini, Paola De Compadri, Daniela Koleva, Luca Pasina, Alessandro Nobili

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: This literature review makes a critical assessment of the methodology of the full economic evaluations (FEEs) conducted on colorectal cancer (CRC) pharmacological treatments. Method: A literature search of the international databases PubMed and EMBASE was carried out to find all the studies published in the English language on pharmacological treatments for CRC in the period 2001-2005. A checklist was adopted to analyse the 13 FEEs selected. Fourteen clinical trials were extracted from the references as sources of efficacy data and were reviewed separately according to a clinical checklist. Finally, the reliability of the 13 FEEs was assessed from the health authorities' perspective by applying a critical appraisal checklist of 16 items derived from the economic and clinical variables previously analysed. Results: This review found that pharmacoeconomic studies on CRC showed important methodological weaknesses mainly regarding economic evaluation, whilst the sources of clinical evidence were of higher technical quality, although the clinical effectiveness of therapies was not fully sustained by their results.

Original languageEnglish
Pages (from-to)177-197
Number of pages21
JournalJournal of Medical Economics
Volume11
Issue number1
DOIs
Publication statusPublished - 2008

Fingerprint

Cost-Benefit Analysis
Colorectal Neoplasms
Checklist
Pharmacology
Pharmaceutical Economics
Information Storage and Retrieval
PubMed
Language
Economics
Clinical Trials
Databases
Health
Therapeutics

Keywords

  • CRC
  • Economic evaluation
  • Pharmacological treatments
  • Review

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

A critical review of the full economic evaluations of pharmacological treatments for colorectal cancer. / Garattini, Livio; De Compadri, Paola; Koleva, Daniela; Pasina, Luca; Nobili, Alessandro.

In: Journal of Medical Economics, Vol. 11, No. 1, 2008, p. 177-197.

Research output: Contribution to journalArticle

@article{f0e35543228c4ae890eea3db5a36fb70,
title = "A critical review of the full economic evaluations of pharmacological treatments for colorectal cancer",
abstract = "Objective: This literature review makes a critical assessment of the methodology of the full economic evaluations (FEEs) conducted on colorectal cancer (CRC) pharmacological treatments. Method: A literature search of the international databases PubMed and EMBASE was carried out to find all the studies published in the English language on pharmacological treatments for CRC in the period 2001-2005. A checklist was adopted to analyse the 13 FEEs selected. Fourteen clinical trials were extracted from the references as sources of efficacy data and were reviewed separately according to a clinical checklist. Finally, the reliability of the 13 FEEs was assessed from the health authorities' perspective by applying a critical appraisal checklist of 16 items derived from the economic and clinical variables previously analysed. Results: This review found that pharmacoeconomic studies on CRC showed important methodological weaknesses mainly regarding economic evaluation, whilst the sources of clinical evidence were of higher technical quality, although the clinical effectiveness of therapies was not fully sustained by their results.",
keywords = "CRC, Economic evaluation, Pharmacological treatments, Review",
author = "Livio Garattini and {De Compadri}, Paola and Daniela Koleva and Luca Pasina and Alessandro Nobili",
year = "2008",
doi = "10.3111/13696990801995940",
language = "English",
volume = "11",
pages = "177--197",
journal = "Journal of Medical Economics",
issn = "1369-6998",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - A critical review of the full economic evaluations of pharmacological treatments for colorectal cancer

AU - Garattini, Livio

AU - De Compadri, Paola

AU - Koleva, Daniela

AU - Pasina, Luca

AU - Nobili, Alessandro

PY - 2008

Y1 - 2008

N2 - Objective: This literature review makes a critical assessment of the methodology of the full economic evaluations (FEEs) conducted on colorectal cancer (CRC) pharmacological treatments. Method: A literature search of the international databases PubMed and EMBASE was carried out to find all the studies published in the English language on pharmacological treatments for CRC in the period 2001-2005. A checklist was adopted to analyse the 13 FEEs selected. Fourteen clinical trials were extracted from the references as sources of efficacy data and were reviewed separately according to a clinical checklist. Finally, the reliability of the 13 FEEs was assessed from the health authorities' perspective by applying a critical appraisal checklist of 16 items derived from the economic and clinical variables previously analysed. Results: This review found that pharmacoeconomic studies on CRC showed important methodological weaknesses mainly regarding economic evaluation, whilst the sources of clinical evidence were of higher technical quality, although the clinical effectiveness of therapies was not fully sustained by their results.

AB - Objective: This literature review makes a critical assessment of the methodology of the full economic evaluations (FEEs) conducted on colorectal cancer (CRC) pharmacological treatments. Method: A literature search of the international databases PubMed and EMBASE was carried out to find all the studies published in the English language on pharmacological treatments for CRC in the period 2001-2005. A checklist was adopted to analyse the 13 FEEs selected. Fourteen clinical trials were extracted from the references as sources of efficacy data and were reviewed separately according to a clinical checklist. Finally, the reliability of the 13 FEEs was assessed from the health authorities' perspective by applying a critical appraisal checklist of 16 items derived from the economic and clinical variables previously analysed. Results: This review found that pharmacoeconomic studies on CRC showed important methodological weaknesses mainly regarding economic evaluation, whilst the sources of clinical evidence were of higher technical quality, although the clinical effectiveness of therapies was not fully sustained by their results.

KW - CRC

KW - Economic evaluation

KW - Pharmacological treatments

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=42949149229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42949149229&partnerID=8YFLogxK

U2 - 10.3111/13696990801995940

DO - 10.3111/13696990801995940

M3 - Article

C2 - 19450119

AN - SCOPUS:42949149229

VL - 11

SP - 177

EP - 197

JO - Journal of Medical Economics

JF - Journal of Medical Economics

SN - 1369-6998

IS - 1

ER -